Evolent health, inc. (EVH)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenue
Revenue from Contract with Customer, Excluding Assessed Tax

846,383

627,063

434,950

254,188

96,878

0

25,671

Expenses
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below)

513,059

327,825

269,352

155,177

57,398

0

30,018

Claims expenses

135,774

70,889

0

0

-

-

-

Selling, General and Administrative Expense

257,046

235,418

205,670

160,692

75,286

0

15,600

Depreciation, Depletion and Amortization, Nonproduction

60,913

44,515

32,368

17,224

7,166

0

1,208

Gain on disposal of assets

9,600

0

0

-

-

-

-

Goodwill impairment

199,800

0

0

160,600

0

0

-

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

-3,997

-4,104

400

-2,086

0

0

-

Operating Expenses

1,152,995

674,543

507,790

491,607

139,850

0

46,826

Operating loss

-306,612

-47,480

-72,840

-237,419

-42,972

0

-21,155

Interest income

3,987

3,440

1,656

970

293

-

-

Interest expense

14,534

5,484

3,636

247

0

0

-820

Gain on consolidation

-

-

-

-

414,133

0

0

Gain on deconsolidation

-

-

-

-

-

-

46,246

Income (Loss) from Equity Method Investments

-9,465

-4,736

-1,755

-841

-28,165

-25,246

-4,241

Other income (expense), net

-492

109

171

4

0

0

1

Loss before income taxes and non-controlling interests

-327,116

-54,151

-76,404

-237,533

343,289

-25,246

20,031

Provision (benefit) for income taxes

-21,536

40

-6,637

-10,755

23,475

0

8

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

-305,580

-54,191

-69,767

-226,778

319,814

-25,246

20,023

Net Income (Loss) Attributable to Noncontrolling Interest

-3,609

-1,533

-9,102

-67,036

-12,680

0

0

Net loss attributable to common shareholders of Evolent Health, Inc.

-301,971

-52,658

-60,665

-159,742

332,494

-25,246

20,023

Basic

-

-

-

-

330,310

-31,137

2,418

Diluted

-

-

-

-

319,814

-31,137

2,957

Loss per common share
Basic and diluted (in dollars per share)

-3.67

-0.68

-0.94

-3.55

-

-

-

Basic (in dollars per share)

-

-

-

-

13.14

-13.46

2.51

Diluted (in dollars per share)

-

-

-

-

6.93

-13.46

0.99

Weighted-average common shares outstanding
Weighted Average Number of Shares Outstanding, Basic and Diluted

82,364

77,338

64,351

45,031

-

-

-

Basic (in shares)

-

-

-

-

25,129

2,314

964

Diluted (in shares)

-

-

-

-

46,136

2,314

2,988

Comprehensive loss
Net loss

-305,580

-54,191

-69,767

-226,778

-

-

-

Other comprehensive loss, net of taxes, related to:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax

-52

-182

0

0

-

-

-

Total comprehensive loss

-305,632

-54,373

-69,767

-226,778

-

-

-

Total comprehensive loss attributable to non-controlling interests

-3,609

-1,533

-9,102

-67,036

-

-

-

Total comprehensive loss attributable to common shareholders of Evolent Health, Inc.

-302,023

-52,840

-60,665

-159,742

-

-

-

Transformation services
Revenue from Contract with Customer, Excluding Assessed Tax

15,203

32,916

29,466

38,320

19,906

0

22,130

Platform and operations services
Revenue from Contract with Customer, Excluding Assessed Tax

659,438

500,190

405,484

215,868

76,972

0

3,541

Premiums
Revenue from Contract with Customer, Excluding Assessed Tax

171,742

93,957

0

0

-

-

-